Literature DB >> 8263685

Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation.

R L Moss1, J B Das, J G Raffensperger.   

Abstract

Cholestatic jaundice is the major complication of total parenteral nutrition (TPN) in infants and children. The pathogenesis of this syndrome is poorly understood. The aims of this study were: (1) to define the histologic liver injury in relation to the clinical course of infants on TPN and (2) to determine whether enteral feeding will reverse or halt these changes. We identified 31 infants treated for severe gastrointestinal disease for whom liver histology was available from 1987 to 1991. Clinical records and liver biopsy (23) or autopsy specimens (13) were reviewed. Five patients had biopsies at two subsequent operations. The clinical diagnosis was necrotizing enterocolitis (24), atresia or stenosis (3), midgut volvulus (2), Hirschsprung's disease (1), and sepsis (1). Twenty-one of 31 infants were premature and had a mean birth weight of 1,868 g. Twenty-five of 31 were on TPN and 28 of 31 had received some enteral feeding by the time of the biopsy. Enteral feeding was begun as early as possible in all infants even if continued TPN was necessary for full support. Cholestasis occurred in 71% of premature infants versus 22% of full-term babies. Infants with cholestasis had been on TPN for a longer time (37 days v 18) with a correspondingly shorter period of enteral feeding (17 days v 27). Mean total bilirubin level was 14 in patients with cholestasis and 5 in those without, but the bilirubin level did not correlate with the extent of histological injury and was frequently normal despite marked histological damage.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8263685     DOI: 10.1016/s0022-3468(05)80311-2

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

1.  Omega-3 long chain polyunsaturated Fatty acids for treatment of parenteral nutrition-associated liver disease: a review of the literature.

Authors:  Emma M Tillman; Richard A Helms
Journal:  J Pediatr Pharmacol Ther       Date:  2011-01

2.  Effects of glutamine isomers on human (Caco-2) intestinal epithelial proliferation, strain-responsiveness, and differentiation.

Authors:  M Murnin; A Kumar; G D Li; M Brown; B E Sumpio; M D Basson
Journal:  J Gastrointest Surg       Date:  2000 Jul-Aug       Impact factor: 3.452

3.  [13C]Methionine breath test to assess intestinal failure-associated liver disease.

Authors:  Debora Duro; Shimae Fitzgibbons; Clarissa Valim; Chi-Fu Jeffrey Yang; David Zurakowski; Melanie Dolan; Lori Bechard; Yong Ming Yu; Christopher Duggan; Tom Jaksic
Journal:  Pediatr Res       Date:  2010-10       Impact factor: 3.756

4.  Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.

Authors:  Kara L Calkins; James C Y Dunn; Stephen B Shew; Laurie Reyen; Douglas G Farmer; Sherin U Devaskar; Robert S Venick
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-07-26       Impact factor: 4.016

5.  The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy.

Authors:  Prathima Nandivada; Melissa I Chang; Alexis K Potemkin; Sarah J Carlson; Eileen Cowan; Alison A Oʼloughlin; Paul D Mitchell; Kathleen M Gura; Mark Puder
Journal:  Ann Surg       Date:  2015-01       Impact factor: 12.969

6.  Relationship between biopsy-proven parenteralnutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome.

Authors:  Shimae C Fitzgibbons; Brian A Jones; Melissa A Hull; David Zurakowski; Debora Duro; Christopher Duggan; Dana Boctor; David L Sigalet; Tom Jaksic
Journal:  J Pediatr Surg       Date:  2010-01       Impact factor: 2.545

7.  Association of lipid peroxidation with hepatocellular injury in preterm infants.

Authors:  Barry Weinberger; Kazimierz Watorek; Richard Strauss; Gisela Witz; Mark Hiatt; Thomas Hegyi
Journal:  Crit Care       Date:  2002-08-21       Impact factor: 9.097

8.  Specific microbiome changes in a mouse model of parenteral nutrition associated liver injury and intestinal inflammation.

Authors:  J Kirk Harris; Karim C El Kasmi; Aimee L Anderson; Michael W Devereaux; Sophie A Fillon; Charles E Robertson; Brandie D Wagner; Mark J Stevens; Norman R Pace; Ronald J Sokol
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

9.  Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis.

Authors:  Karim C El Kasmi; Padade M Vue; Aimee L Anderson; Michael W Devereaux; Swati Ghosh; Natarajan Balasubramaniyan; Sophie A Fillon; Carola Dahrenmoeller; Ayed Allawzi; Crystal Woods; Sarah McKenna; Clyde J Wright; Linda Johnson; Angelo D'Alessandro; Julie A Reisz; Eva Nozik-Grayck; Frederick J Suchy; Ronald J Sokol
Journal:  Nat Commun       Date:  2018-04-11       Impact factor: 14.919

10.  Evaluation of parenteral nutrition-associated liver disease in surgical infants for necrotizing enterocolitis.

Authors:  Senyan Zeng; Xiaoyu Li; Chun Deng; Lei Li; Chunbao Guo
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.